O'Byrne K

ORCID: 0000-0002-6754-5633 · 1 paper in corpus

2022

Immune Checkpoint Inhibitors in Cancer Therapy.

Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol29050247

The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized monoclonal antibodies, targeting these immune checkpoint proteins hav…